1,002
Views
11
CrossRef citations to date
0
Altmetric
Reports

Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model

, , ORCID Icon, , , , , , , , , , , , M.D., FACS, , M.D., Ph.D. ORCID Icon & , Ph.D. show all
Pages 1008-1014 | Received 24 Jan 2017, Accepted 30 Mar 2017, Published online: 02 May 2017

References

  • Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29; PMID:24399786; http://dx.doi.org/10.3322/caac.21208
  • Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362:1605-17; PMID:20427809; http://dx.doi.org/10.1056/NEJMra0901557
  • Korc M. Pancreatic cancer-associated stroma production. Am J Surg 2007; 194(4 Suppl):S84-86; PMID:17903452; http://dx.doi.org/10.1016/j.amjsurg.2007.05.004
  • Saluja AK, Dudeja V, Banerjee S. Evolution of novel therapeutic options for pancreatic cancer. Curr Opin Gastroenterol 2016; 7:401-407.
  • Katz LH, Likhter M, Jogunoori W, Belkin M, Ohshiro K, Mishra L. TGF-β signaling in liver and gastrointestinal cancers. Cancer Lett 2016; 379:166-172; PMID:27039259; http://dx.doi.org/10.1016/j.canlet.2016.03.033
  • Yang M, Li L, Jiang P, Moossa A, R Penman S, Hoffman RM. Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci USA 2003; 100:14259-262; PMID:14614130; http://dx.doi.org/10.1073/pnas.2436101100
  • Yang M, Reynoso J, Jiang P, Li L, Moossa AR, Hoffman RM. Transgenic nude mouse with ubiquitous green fluorescent protein expression as a host for human tumors. Cancer Res 2004; 64:8651-56; PMID:15574773; http://dx.doi.org/10.1158/0008-5472.CAN-04-3118
  • Yang M, Reynoso J, Bouvet M, Hoffman RM. A transgenic red fluorescent protein-expressing nude mouse for color-coded imaging of the tumor microenvironment. J Cell Biochem 2009; 106:279-84; PMID:19097136; http://dx.doi.org/10.1002/jcb.21999
  • Hoffman RM, Yang M. Color-coded fluorescence imaging of tumor-host interactions. Nat Protocols 2006; 1:928-35; PMID:17406326; http://dx.doi.org/10.1038/nprot.2006.119
  • Bouvet M, Tsuji K, Yang M, Jiang P, Moossa AR, Hoffman RM. In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res 2006; 66:11293-297; PMID:17145875; http://dx.doi.org/10.1158/0008-5472.CAN-06-2662
  • Suetsugu A, Katz M, Fleming J, Truty M, Thomas R, Saji S, Moriwaki H, Bouvet M, Hoffman RM. Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens. Anticancer Res 2012; 32:1175-80; PMID:22493347
  • Suetsugu A, Katz M, Fleming J, Truty M, Thomas R, Saji S, Moriwaki H, Bouvet M, Hoffman RM. Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer-patient tumorgraft progression in nude mice. Anticancer Res 2012; 32:3063-68; PMID:22843874
  • Yang M, Jiang P, Hoffman RM. Whole-body subcellular multicolor imaging of tumor-host interaction and drug response in real time. Cancer Res 2007; 67:5195-200; PMID:17545599; http://dx.doi.org/10.1158/0008-5472.CAN-06-4590
  • Bouvet M, Wang J, Nardin SR, Nassirpour R, Yang M, Baranov E, Jiang P, Moossa AR, Hoffman RM. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 2002; 62:1534-40; PMID:11888932
  • Bouvet M, Yang M, Nardin S, Wang X, Jiang P, Baranov E, Moossa AR, Hoffman RM. Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models. Clin Exp Metastasis 2000; 18:213-18; PMID:11315094; http://dx.doi.org/10.1023/A:1006767405609
  • Cai WX, Zheng LW, Huang HZ, Zwahlen RA. Evidence of phenotypic stability after transduction of fluorescent proteins in two human tongue cancer cell lines. Archives Oral Biol 2017; 79:48-54; PMID:28288391; http://dx.doi.org/10.1016/j.archoralbio.2017.03.002
  • Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 2005; 5:796-806; PMID:16195751; http://dx.doi.org/10.1038/nrc1717
  • Hoffman RM, Yang M. Subcellular imaging in the live mouse. Nat Protocols 2006; 1:775-82; PMID:17406307; http://dx.doi.org/10.1038/nprot.2006.109
  • Hoffman RM, Yang M. Whole-body imaging with fluorescent proteins. Nat Protocols 2006; 1:1429-38; PMID:17406431; http://dx.doi.org/10.1038/nprot.2006.223
  • Tran Cao HS, Reynoso J, Yang M, Kimura H, Kaushal S, Snyder CS, Hoffman RM, Bouvet M. Development of the transgenic cyan fluorescent protein (CFP)-expressing nude mouse for “Technicolor” cancer imaging. J Cell Biochem 2009; 107:328-34; PMID:19306297; http://dx.doi.org/10.1002/jcb.22128
  • Blagosklonny MV. Matching targets for selective cancer therapy. Drug Discov Today 2003; 8:1104-07; PMID:14678733; http://dx.doi.org/10.1016/S1359-6446(03)02806-X
  • Blagosklonny MV. Teratogens as anti-cancer drugs. Cell Cycle 2005; 4:1518-21; PMID:16258270; http://dx.doi.org/10.4161/cc.4.11.2208
  • Blagosklonny MV. Treatment with inhibitors of caspases, that are substrates of drug ransporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells. Leukemia 2001; 15:936-41; PMID:11417480; http://dx.doi.org/10.1038/sj.leu.2402127
  • Blagosklonny MV. Target for cancer therapy: Proliferating cells or stem cells. Leukemia 2006; 20:385-91; PMID:16357832; http://dx.doi.org/10.1038/sj.leu.2404075
  • Apontes P, Leontieva OV, Demidenko ZN, Li F, Blagosklonny MV. Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture. Oncotarget 2011; 2:222-33; PMID:21447859; http://dx.doi.org/10.18632/oncotarget.248
  • Blagosklonny MV. Tissue-selective therapy of cancer. Br J Cancer 2003; 89:1147-51; PMID:14520435; http://dx.doi.org/10.1038/sj.bjc.6601256
  • Fu X, Guadagni F, Hoffman RM. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically from histologically intact patient specimens. Proc Natl Acad Sci USA 1992; 89:5645-49; PMID:1608975; http://dx.doi.org/10.1073/pnas.89.12.5645
  • Furukawa T, Kubota T, Watanabe M, Kitajima M, Hoffman RM. A novel “patient-like” treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res 1993; 53:3070-72; PMID:8319214
  • Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic. Investigational New Drugs 1999; 17:343-59; PMID:10759402; http://dx.doi.org/10.1023/A:1006326203858
  • Hoffman RM. Orthotopic is orthodox: Why are orthotopic-transplant metastatic models different from all other models? J Cell Biochem 1994; 56:1-3; http://dx.doi.org/10.1002/jcb.240560102
  • Yamauchi K, Yang M, Jiang P, Xu M, Yamamoto N, Tsuchiya H, Tomita K, Moossa AR, Bouvet M, Hoffman RM. Development of real-time subcellular dynamic multicolor imaging of cancer-cell trafficking in live mice with a variable-magnification whole-mouse imaging system. Cancer Res 2006; 66:4208-14; PMID:16618743; http://dx.doi.org/10.1158/0008-5472.CAN-05-3927
  • Uchugonova A, Duong J, Zhang N, König K, Hoffman RM. The bulge area is the origin of nestin-expressing pluripotent stem cells of the hair follicle. J Cell Biochem 2011; 112:2046-50; PMID:21465525; http://dx.doi.org/10.1002/jcb.23122

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.